Article Details
Retrieved on: 2018-03-04 10:26:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Millennium Management</b> LLC raised its position in Summit Therapeutics by 29.5% in the 4th quarter. <b>Millennium Management</b> LLC now owns 99,873 shares of the company's stock valued at $1,107,000 after buying an additional 22,759 shares during the last quarter. Alyeska Investment Group L.P. ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here